LASE vs. CRBP
LASE (Laser Photonics Corporation) and CRBP (Corbus Pharmaceuticals Holdings, Inc.) are both stocks. LASE operates in Specialty Industrial Machinery (Industrials), while CRBP operates in Biotechnology (Healthcare). Over the past 3 years, LASE returned -10.27%/yr vs -1.27%/yr for CRBP. At a 0.07 correlation, their price movements are largely independent.
Performance
LASE vs. CRBP - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, LASE achieves a -12.55% return, which is significantly lower than CRBP's 3.93% return.
LASE
- 1D
- 1.41%
- 1M
- 140.59%
- YTD
- -12.55%
- 6M
- -17.87%
- 1Y
- 13.68%
- 3Y*
- -10.27%
- 5Y*
- —
- 10Y*
- —
CRBP
- 1D
- 1.81%
- 1M
- -25.46%
- YTD
- 3.93%
- 6M
- 3.30%
- 1Y
- 7.22%
- 3Y*
- -1.27%
- 5Y*
- -32.88%
- 10Y*
- -21.03%
LASE vs. CRBP - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|---|
LASE Laser Photonics Corporation | -12.55% | -57.27% | 389.83% | -42.16% | -59.20% |
CRBP Corbus Pharmaceuticals Holdings, Inc. | 3.93% | -31.02% | 95.36% | 82.20% | -36.78% |
Correlation
The correlation between LASE and CRBP is 0.09, meaning there is essentially no relationship between their price movements. Each responds to its own set of market drivers, making them strong candidates for combining in a diversified portfolio.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.09 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.08 |
Correlation (All Time) Calculated using the full available price history since Sep 30, 2022 | 0.07 |
Fundamentals
LASE:
-$0.48
CRBP:
-$5.98
LASE:
$7.14M
CRBP:
$0.00
LASE:
$2.22M
CRBP:
-$149.00K
LASE:
-$8.37M
CRBP:
-$61.36M
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
LASE vs. CRBP — Risk / Return Rank
LASE
CRBP
LASE vs. CRBP - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Laser Photonics Corporation (LASE) and Corbus Pharmaceuticals Holdings, Inc. (CRBP). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| LASE | CRBP | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -0.03 | ||
| Sortino ratioReturn per unit of downside risk | +1.35 | ||
| Omega ratioGain probability vs. loss probability | 1.26 | 1.10 | +0.15 |
| Calmar ratioReturn relative to maximum drawdown | 0.15 | 0.12 | +0.03 |
| Martin ratioReturn relative to average drawdown | 0.22 | 0.17 | +0.05 |
Loading charts...
Drawdowns
LASE vs. CRBP - Drawdown Comparison
The maximum LASE drawdown since its inception was -96.80%, roughly equal to the maximum CRBP drawdown of -99.31%. Use the drawdown chart below to compare losses from any high point for LASE and CRBP.
Loading charts...
Drawdown Indicators
| LASE | CRBP | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -96.80% | -99.31% | +2.51% |
Max Drawdown (1Y)Largest decline over 1 year | -90.76% | -61.88% | -28.88% |
Max Drawdown (3Y)Largest decline over 3 years | -96.80% | -92.01% | -4.79% |
Max Drawdown (5Y)Largest decline over 5 years | — | -96.30% | — |
Max Drawdown (10Y)Largest decline over 10 years | — | -99.31% | — |
Current DrawdownCurrent decline from peak | -88.51% | -97.28% | +8.77% |
Average DrawdownAverage peak-to-trough decline | -70.83% | -66.12% | -4.71% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 62.84% | 42.01% | +20.83% |
Volatility
LASE vs. CRBP - Volatility Comparison
Laser Photonics Corporation (LASE) has a higher volatility of 113.94% compared to Corbus Pharmaceuticals Holdings, Inc. (CRBP) at 39.34%. This indicates that LASE's price experiences larger fluctuations and is considered to be riskier than CRBP based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| LASE | CRBP | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 113.94% | 39.34% | +74.60% |
Volatility (6M)Calculated over the trailing 6-month period | 150.27% | 60.28% | +89.99% |
Volatility (1Y)Calculated over the trailing 1-year period | 235.55% | 81.56% | +153.99% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 186.82% | 159.23% | +27.59% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 186.82% | 129.12% | +57.70% |
Dividends
LASE vs. CRBP - Dividend Comparison
Neither LASE nor CRBP has paid dividends to shareholders.
Financials
LASE vs. CRBP - Financials Comparison
This section allows you to compare key financial metrics between Laser Photonics Corporation and Corbus Pharmaceuticals Holdings, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
Frequently Asked Questions
LASE and CRBP have a correlation of 0.09, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
LASE has higher volatility (113.94%) compared to CRBP (39.34%). In terms of maximum drawdown, LASE dropped -96.80% vs CRBP's -99.31%.
CRBP currently has the higher Sharpe Ratio (0.09 vs 0.06), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for LASE and CRBP
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer